Mode
Text Size
Log in / Sign up
N/A N=45 Randomized Double-blind Treatment

Assessment of Ridge Preservation Using Moldable Beta-tricalcium Phosphate Bone Grafting System

Dental Implants · Alveolar Ridge Preservation

Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Change in Radiographic Measurements of Ridge Dimension (Horizontal Ridge Width) — 1.26; 1.28 mm

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
easy-graft CLASSIC (Device); FDBA with collagen plug (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Sunstar Americas
Primary completion
Aug 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Radiographic Measurements of Ridge Dimension (Horizontal Ridge Width)
1.26; 1.28
PRIMARY
Change in Radiographic Measurements of Ridge Dimension (Volumetric Assessment)
23.9; 17.0
SECONDARY
Histomorphometric Assessment of Newly Formed Mineralized Tissue
27.0; 38.2
SECONDARY
Histomorphometric Assessment of Residual Bone Graft Particles
20.5; 15.7
SECONDARY
Histomorphometric Assessment of Non-mineralized Tissue
52.5; 46.1
SECONDARY
Change of Marginal Bone Level Around Dental Implant
0.04; 0.06; 0.12; -0.05; 0.02; 0.02

Summary

Randomized Controlled study to compare the effectiveness of two different treatment approaches using a new moldable beta-tricalcium phosphate(TCP) bone graft material in ridge preservation of an atraumatic extraction socket site compared to allograft with collagen plug.

Eligibility Criteria

Inclusion Criteria

  • Provision of informed consent
  • At least 18 years old
  • In need of one posterior tooth, excluding third molar molars, planned for extraction and replacement with a dental implant (If the subject requires two adjacent socket preservation, they can still be enrolled in the study but only one site will be used for the study)
  • Intact ridge as verified with cone-beam CT scan
  • At least one natural tooth adjacent to the study site present.

Exclusion Criteria

  • Insufficient interocclusal space to allow for implant supported prosthesis
  • Dehiscence or fenestration identified at the time of reviewing CBCT.
  • Non-treated caries or uncontrolled periodontal disease present affecting the teeth in adjacent to study teeth.
  • Any of natural teeth adjacent to the study site presents active periapical endodontic lesion ("active periapical endodontic lesion" will be determined per consultation by endodontics specialist).
  • Adjacent tooth (mesial and distal) to study site was extracted within last 6 months
  • Adjacent teeth (or tooth) to study site with significant soft tissue loss
  • Smoker using more than 10 cigarettes or equivalent per day
  • Smokeless tobacco use or e-cigarette use
  • Current alcohol or drug abuser
  • Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration e.g. uncontrolled diabetes
  • Need for systemic corticosteroids or any other medication that would influence post-operative healing and/or osseointegration
  • Pregnancy, as indicated by positive serum human chorionic gonadotropin (HCG) test result.
  • Unable or unwilling to return for follow-up visits for a period of 5 months
  • Unlikely to be able to comply with study procedures according to Investigators judgement
  • Subject in other clinical trials
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02702609). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search